This is the first human cancer vaccine study to see T-cell responses in the absence of B-cells. This paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B-cells.
This is the first human cancer vaccine study to see T-cell responses in the absence of B-cells. This paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B-cells.
Tissue loss follows T-cell loss, meaning that people with poor immune function also show severe brain damage. This was a revelation. We used to consider these separate phenomena, because HIV harms the brain and immune system in different ways. Now we see they are intrinsically linked.
This additional capital is a tremendous catalyst for the company and will provide us with the financial resources to implement our clinical program, for both our T-cell and stem cell technologies and to fulfill their potential as life-saving therapies. We believe that the strengthening of our capital structure in connection with the reverse stock split will provide the backbone for a strong organization with prospects for a Nasdaq listing.
© 2020 Inspirational Stories
© 2020 Inspirational Stories